• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病的流行病学

Epidemiology of Parkinson's disease.

作者信息

Kasten Meike, Chade Annabel, Tanner Caroline M

出版信息

Handb Clin Neurol. 2007;83:129-51. doi: 10.1016/S0072-9752(07)83006-5.

DOI:10.1016/S0072-9752(07)83006-5
PMID:18808913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7112363/
Abstract

This chapter discusses the epidemiology of Parkinson's disease (PD). Classically, PD refers to progressive parkinsonism caused by loss of pigmented aminergic brainstem neurons without an identifiable cause, while parkinsonism refers simply to the syndrome of bradykinesia, resting tremor, rigidity and postural reflex impairment. Over nearly two centuries, Parkinson's clinical description has provided the framework for clinical investigations, including epidemiologic ones. Descriptions of PD were limited to selected clinical settings until the middle of the 20th century. Since then, epidemiologic approaches have been used not only to investigate the population distribution of PD, but also as a way to glean clues as to the cause of this “idiopathic” disorder. Because PD is relatively infrequent, a large base population must be surveyed to identify sufficient numbers of cases for a study. In some instances, PD cases can be identified through health service rosters within defined geographic areas or in enumerated populations. In others, cases of PD are sought independently of the health care system, such as through door-to-door surveys. While the latter approach is theoretically least likely to exclude cases, the time and cost involved are also greatest using this approach.

摘要

本章讨论帕金森病(PD)的流行病学。传统上,PD指由脑干色素性胺能神经元丧失所致的进行性帕金森综合征,病因不明,而帕金森综合征仅指运动迟缓、静止性震颤、肌强直和姿势反射受损的综合征。近两个世纪以来,帕金森病的临床描述为包括流行病学研究在内的临床研究提供了框架。直到20世纪中叶,对PD的描述还局限于特定的临床环境。从那时起,流行病学方法不仅用于调查PD在人群中的分布,还用于寻找有关这种“特发性”疾病病因的线索。由于PD相对少见,必须对大量人群进行调查,以确定足够数量的病例用于研究。在某些情况下,可以通过特定地理区域内的卫生服务名册或普查人群来识别PD病例。在其他情况下,则独立于卫生保健系统寻找PD病例,如通过挨家挨户的调查。虽然后一种方法理论上最不可能排除病例,但采用这种方法所需的时间和成本也最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/7112363/dfb06f3ad5b0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/7112363/739dab24ee26/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/7112363/dfb06f3ad5b0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/7112363/739dab24ee26/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/7112363/dfb06f3ad5b0/gr2.jpg

相似文献

1
Epidemiology of Parkinson's disease.帕金森病的流行病学
Handb Clin Neurol. 2007;83:129-51. doi: 10.1016/S0072-9752(07)83006-5.
2
Parkinson's disease in China: a forty-year growing track of bedside work.中国的帕金森病:四十年床边工作的发展轨迹
Transl Neurodegener. 2019 Jul 31;8:22. doi: 10.1186/s40035-019-0162-z. eCollection 2019.
3
Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.帕金森病:流行病学、(鉴别)诊断、治疗、与痴呆的关系。
Arzneimittelforschung. 1995 Mar;45(3A):386-9.
4
Epidemiology of Parkinson's disease.帕金森病的流行病学
Parkinsonism Relat Disord. 1997 Dec;3(4):175-86. doi: 10.1016/s1353-8020(97)00029-1.
5
Epidemiology of Parkinson's disease--an overview.帕金森病的流行病学——概述
J Neural Transm. 1981;51(1-2):135-48. doi: 10.1007/BF01664011.
6
[Dementia in Parkinson's disease].[帕金森病中的痴呆症]
Braz J Psychiatry. 2008 Dec;30(4):375-83. doi: 10.1590/s1516-44462008000400013.
7
Parkinson's Disease and Cognitive Impairment.帕金森病与认知障碍
Parkinsons Dis. 2016;2016:6734678. doi: 10.1155/2016/6734678. Epub 2016 Dec 12.
8
Changing epidemiology of Parkinson's disease: predicted effects of levodopa treatment.帕金森病流行病学的变化:左旋多巴治疗的预测效果
Acta Neurol Scand. 1979 Mar;59(2-3):80-7. doi: 10.1111/j.1600-0404.1979.tb02914.x.
9
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.欧洲帕金森综合征和帕金森病的患病率:EUROPARKINSON协作研究。欧洲共同体帕金森病流行病学联合行动。
J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):10-5. doi: 10.1136/jnnp.62.1.10.
10
Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson's disease, atypical Parkinsonian disorders and non-Parkinsonian populations.帕金森病、非典型帕金森综合征及非帕金森病群体中冲动强迫行为的现象学与流行病学
J Neurol Sci. 2017 Mar 15;374:47-52. doi: 10.1016/j.jns.2016.12.058. Epub 2016 Dec 28.

引用本文的文献

1
Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study.巴西帕金森病的患病率、分布及未来预测:来自巴西ELSI队列研究的见解
Lancet Reg Health Am. 2025 Mar 28;44:101046. doi: 10.1016/j.lana.2025.101046. eCollection 2025 Apr.
2
The epidemiology of Parkinson's disease.帕金森病的流行病学。
Lancet. 2024 Jan 20;403(10423):283-292. doi: 10.1016/S0140-6736(23)01419-8.
3
Effect of best practice advisory on the administration of contraindicated medications to hospitalized patients with Parkinson's disease and related disorders.

本文引用的文献

1
Head injury and Parkinson's disease risk in twins.双胞胎中的头部损伤与帕金森病风险
Ann Neurol. 2006 Jul;60(1):65-72. doi: 10.1002/ana.20882.
2
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease.非甾体抗炎药与帕金森病的发病率
Neurology. 2006 Apr 11;66(7):1097-9. doi: 10.1212/01.wnl.0000204446.82823.28.
3
Survival of Parkinson's disease patients in a large prospective cohort of male health professionals.帕金森病患者在一个大型男性健康专业人员前瞻性队列中的生存情况。
最佳实践建议对帕金森病及相关疾病住院患者禁忌药物给药的影响。
Front Aging Neurosci. 2023 Dec 18;15:1276761. doi: 10.3389/fnagi.2023.1276761. eCollection 2023.
4
Chronic effects of different exercise types on brain activity in healthy older adults and those with Parkinson's disease: A systematic review.不同运动类型对健康老年人和帕金森病患者大脑活动的长期影响:一项系统综述。
Front Physiol. 2022 Nov 28;13:1031803. doi: 10.3389/fphys.2022.1031803. eCollection 2022.
5
Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study.拉丁美洲城乡人口中帕金森综合征和帕金森病的患病率:一项基于社区的研究。
Lancet Reg Health Am. 2022 Mar;7:None. doi: 10.1016/j.lana.2021.100136.
6
Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's Disease.哥斯达黎加帕金森病患者的临床与基因分析
Front Neurol. 2021 Aug 4;12:656342. doi: 10.3389/fneur.2021.656342. eCollection 2021.
7
The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings.罗斯托克国际帕金森病(ROPAD)研究:方案与初步发现。
Mov Disord. 2021 Apr;36(4):1005-1010. doi: 10.1002/mds.28416. Epub 2020 Dec 14.
8
Impact of Safety Warning on Domperidone Prescribing for Geriatric Patients in South Korea: Analysis of National Insurance Claim Data.安全警示对韩国老年患者开具多潘立酮处方的影响:国家保险索赔数据分析。
Int J Environ Res Public Health. 2019 Aug 20;16(16):2985. doi: 10.3390/ijerph16162985.
9
L-Dopa and Brain Serotonin System Dysfunction.左旋多巴与脑血清素系统功能障碍。
Toxics. 2015 Mar 5;3(1):75-88. doi: 10.3390/toxics3010075.
10
Progressive decline of glucocerebrosidase in aging and Parkinson's disease.葡萄糖脑苷脂酶在衰老和帕金森病中的进行性下降。
Ann Clin Transl Neurol. 2015 Apr;2(4):433-8. doi: 10.1002/acn3.177. Epub 2015 Feb 6.
Mov Disord. 2006 Jul;21(7):1002-7. doi: 10.1002/mds.20881.
4
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.LRRK2基因G2019S突变是阿什肯纳兹犹太人患帕金森病的一个病因。
N Engl J Med. 2006 Jan 26;354(4):424-5. doi: 10.1056/NEJMc055509.
5
Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders.瑞典焊工全国大型队列研究中的帕金森病及其他基底神经节或运动障碍
Occup Environ Med. 2006 Feb;63(2):135-40. doi: 10.1136/oem.2005.022921.
6
GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.糖原合成酶激酶3β基因多态性改变帕金森病中的转录和剪接。
Ann Neurol. 2005 Dec;58(6):829-39. doi: 10.1002/ana.20691.
7
Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.帕金森病与亮氨酸重复激酶2(LRRK2):美国运动障碍诊所中一种常见突变的频率
Mov Disord. 2006 Apr;21(4):519-23. doi: 10.1002/mds.20751.
8
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.非甾体抗炎药的使用与帕金森病风险
Ann Neurol. 2005 Dec;58(6):963-7. doi: 10.1002/ana.20682.
9
G2019S LRRK2 mutation in French and North African families with Parkinson's disease.患有帕金森病的法国和北非家庭中的G2019S LRRK2突变
Ann Neurol. 2005 Nov;58(5):784-7. doi: 10.1002/ana.20636.
10
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.生殖因素及绝经后激素使用对帕金森病风险的影响。
Neurology. 2005 Aug 9;65(3):383-90. doi: 10.1212/01.wnl.0000171344.87802.94.